Copyright
©2014 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastrointest Oncol. Feb 15, 2014; 6(2): 52-54
Published online Feb 15, 2014. doi: 10.4251/wjgo.v6.i2.52
Published online Feb 15, 2014. doi: 10.4251/wjgo.v6.i2.52
Extended cancer-free survival after palliative chemoradiation for metastatic esophageal cancer
Hideomi Yamashita, Akihiro Nomoto, Mami Yamashita, Hiroshi Igaki, Departments of Radiology, University of Tokyo Hospital, Tokyo 113-8655, Japan
Kae Okuma, Keiichi Nakagawa, Departments of Palliative Care Unit, University of Tokyo Hospital, Tokyo 113-8655, Japan
Author contributions: Yamashita H, Igaki H and Nakagawa K designed the report; Nomoto A and Yamashita M performed the genetic analyses; Yamashita H and Okuma K collected the patient’s clinical data; Yamashita H, Igaki H and Nakagawa K analyzed the data and wrote the paper.
Correspondence to: Dr. Hideomi Yamashita, MD, PhD, Department of Radiology, University of Tokyo Hospital, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan. yamachan07291973@yahoo.co.jp
Telephone: +81-3-58008667 Fax: +81-3-58008935
Received: October 14, 2013
Revised: December 22, 2013
Accepted: January 6, 2014
Published online: February 15, 2014
Processing time: 123 Days and 20.5 Hours
Revised: December 22, 2013
Accepted: January 6, 2014
Published online: February 15, 2014
Processing time: 123 Days and 20.5 Hours
Core Tip
Core tip: The palliative therapy method has not been confirmed for metastatic esophageal cancer. This case report represents a patient who was cancer-free for an extended period of time after palliative chemoradiation of 30 Gy in 10 fractions. We think that 30 Gy without oblique beams is a more favorable radiotherapy method for patients.